Pneumococcal Vaccines

• 

  Subject Areas on Research

  • A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center. 
  • Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015. 
  • Beyond coverage: Rural-urban disparities in the timeliness of childhood vaccinations in Tanzania. 
  • Blood stream infection is associated with altered heptavalent pneumococcal conjugate vaccine immune responses in very low birth weight infants. 
  • Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions. 
  • Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua. 
  • Chest radiograph reading panel performance in a Bangladesh pneumococcal vaccine effectiveness study. 
  • Coming together at the hinges: Therapeutic prospects of IgG3. 
  • Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana. 
  • Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial. 
  • Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study. 
  • Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine. 
  • Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations. 
  • Good and bad memories following rituximab therapy. 
  • Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants. 
  • Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae. 
  • Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial. 
  • Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy. 
  • Impact of a combined pediatric and adult pneumococcal immunization program on adult pneumonia incidence and mortality in Nicaragua. 
  • Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. 
  • Kinetics of pneumococcal antibodies among HIV-exposed, uninfected infants in Botswana. 
  • Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations. 
  • Pneumococcal (Pneumonia) Vaccines. 
  • Pneumococcal Carriage and Vaccine Coverage in Retirement Community Residents. 
  • Pneumococcal conjugate vaccine: are 3 doses equal to 4 doses? 
  • Prevention of pneumococcal infections in childhood: two decades of progress. 
  • Programmatic challenges in obtaining and confirming the pneumococcal vaccination status of cochlear implant recipients. 
  • Recommended Adult Immunization Schedule, United States, 2020. 
  • Reimmunization to pneumococcus in patients with sickle cell disease: do they or don't they respond? 
  • The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation. 
  • Trends in Otitis Media and Myringotomy With Tube Placement Among American Indian and Alaska Native Children and the US General Population of Children After Introduction of the 13-valent Pneumococcal Conjugate Vaccine. 
  • Update on immunizations in adults. 
  • Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. 
  • Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children.